NCT05406050View on ClinicalTrials.gov

Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

July 15, 2021

Conditions
Healthy
Interventions
DRUG

reference eldecalcitol soft capsule

0.75 μg, produced by Chugai Pharmaceutical Co., Ltd. Japan

DRUG

test eldecalcitol soft capsule

0.75 μg, produced by Wenzhou Haihe Pharmaceutical Co., Ltd. China

Trial Locations (1)

266003

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
collaborator

Wenzhou Haihe Pharmaceutical Co., Ltd.

UNKNOWN

lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05406050 - Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter